123 related articles for article (PubMed ID: 36963539)
1. β-Catenin interacts with the TAZ1 and TAZ2 domains of CBP/p300 to activate gene transcription.
Brown AD; Cranstone C; Dupré DJ; Langelaan DN
Int J Biol Macromol; 2023 May; 238():124155. PubMed ID: 36963539
[TBL] [Abstract][Full Text] [Related]
2. The C-terminal transactivation domain of MITF interacts promiscuously with co-activator CBP/p300.
Brown AD; Lynch K; Langelaan DN
Sci Rep; 2023 Sep; 13(1):16094. PubMed ID: 37752231
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of CBP/p300 recruitment by the microphthalmia-associated transcription factor.
Brown AD; Vergunst KL; Branch M; Blair CM; Dupré DJ; Baillie GS; Langelaan DN
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119520. PubMed ID: 37353163
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the RelA:CBP/p300 interaction reveals its involvement in NF-κB-driven transcription.
Mukherjee SP; Behar M; Birnbaum HA; Hoffmann A; Wright PE; Ghosh G
PLoS Biol; 2013 Sep; 11(9):e1001647. PubMed ID: 24019758
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.
Lochhead MR; Brown AD; Kirlin AC; Chitayat S; Munro K; Findlay JE; Baillie GS; LeBrun DP; Langelaan DN; Smith SP
J Biol Chem; 2020 Mar; 295(13):4303-4315. PubMed ID: 32098872
[TBL] [Abstract][Full Text] [Related]
6. CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding.
De Guzman RN; Wojciak JM; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2005 Jan; 44(2):490-7. PubMed ID: 15641773
[TBL] [Abstract][Full Text] [Related]
7. Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment.
Wang F; Marshall CB; Yamamoto K; Li GY; Gasmi-Seabrook GM; Okada H; Mak TW; Ikura M
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6078-83. PubMed ID: 22474372
[TBL] [Abstract][Full Text] [Related]
8. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
[TBL] [Abstract][Full Text] [Related]
9. Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin.
Labalette C; Renard CA; Neuveut C; Buendia MA; Wei Y
Mol Cell Biol; 2004 Dec; 24(24):10689-702. PubMed ID: 15572674
[TBL] [Abstract][Full Text] [Related]
10. Wnt/β-catenin-dependent acetylation of Pygo2 by CBP/p300 histone acetyltransferase family members.
Andrews PG; Kao KR
Biochem J; 2016 Nov; 473(22):4193-4203. PubMed ID: 27647933
[TBL] [Abstract][Full Text] [Related]
11. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2.
Ferreon JC; Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6591-6. PubMed ID: 19357310
[TBL] [Abstract][Full Text] [Related]
12. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
[TBL] [Abstract][Full Text] [Related]
13. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.
Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000
[TBL] [Abstract][Full Text] [Related]
14. CBP/p300 are bimodal regulators of Wnt signaling.
Li J; Sutter C; Parker DS; Blauwkamp T; Fang M; Cadigan KM
EMBO J; 2007 May; 26(9):2284-94. PubMed ID: 17410209
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domains.
Wojciak JM; Martinez-Yamout MA; Dyson HJ; Wright PE
EMBO J; 2009 Apr; 28(7):948-58. PubMed ID: 19214187
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Lef-mediated transcription and p53-dependent pathway by associating beta-catenin with CBP/p300.
Miyagishi M; Fujii R; Hatta M; Yoshida E; Araya N; Nagafuchi A; Ishihara S; Nakajima T; Fukamizu A
J Biol Chem; 2000 Nov; 275(45):35170-5. PubMed ID: 10906119
[TBL] [Abstract][Full Text] [Related]
17. Cell-type-specific function of BCL9 involves a transcriptional activation domain that synergizes with beta-catenin.
Sustmann C; Flach H; Ebert H; Eastman Q; Grosschedl R
Mol Cell Biol; 2008 May; 28(10):3526-37. PubMed ID: 18347063
[TBL] [Abstract][Full Text] [Related]
18. KLF4 interacts with beta-catenin/TCF4 and blocks p300/CBP recruitment by beta-catenin.
Evans PM; Chen X; Zhang W; Liu C
Mol Cell Biol; 2010 Jan; 30(2):372-81. PubMed ID: 19901072
[TBL] [Abstract][Full Text] [Related]
19. The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates.
Hecht A; Vleminckx K; Stemmler MP; van Roy F; Kemler R
EMBO J; 2000 Apr; 19(8):1839-50. PubMed ID: 10775268
[TBL] [Abstract][Full Text] [Related]
20. Role of the N-terminal activation domain of the coiled-coil coactivator in mediating transcriptional activation by beta-catenin.
Yang CK; Kim JH; Stallcup MR
Mol Endocrinol; 2006 Dec; 20(12):3251-62. PubMed ID: 16931570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
